Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Kravchenko
Successful Outcomes of Brentuximab Vedotin Therapy in Recurrent/Refractory Cutaneous T-Cell Lymphomas: Two Case Reports
Immunopathology, Allergology, Infectology
Related publications
Potentials of Brentuximab Vedotin in the Treatment of Relapse/Refractory Cutaneous T-Cell Lymphomas: Literature Review and Authors’ Observation
Vestnik dermatologii i venerologii
Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Our First Experiences With Brentuximab Vedotin in the Treatment of Cutaneous T-Cell Lymphoma
Bőrgyógyászati és Venerológiai Szemle
Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report
Drugs in R and D
Pharmacology
A Case of Refractory Sézary Syndrome With Large-Cell Transformation Responsive to Brentuximab Vedotin
JAMA Dermatology
Dermatology
Medicine
A Phase Ii Trial of Brentuximab Vedotin (Bv) and Lenalidomide (Len) in Relapsed and Refractory (R/R) Cutaneous (Ctcl) and Peripheral (Ptcl) T-Cell Lymphomas: Preliminary Results of a Phase Ii Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Cutaneous T-Cell Lymphomas: Modern Data of Pathogenesis, Clinics and Therapy
Oncogematologiya
Oncology
Hematology
Multiple Successful Desensitizations to Brentuximab Vedotin: A Case Report and Literature Review
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
An Overview of Cutaneous T Cell Lymphomas
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
